TrademarkDir
REFINEIQ
LIVE

Serial Number

86811738

Owner

INTRINSIQ SPECIALTY SOLUTIONS, INC.

Attorney

Patrick C. Stephenson

First Use Date

May 31, 2017

Filing Date

Nov 6, 2015

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

REFINEIQ Trademark

Serial Number: 86811738 • Registration: 5387190

REFINEIQ is a trademark filed by INTRINSIQ SPECIALTY SOLUTIONS, INC. on November 6, 2015. The trademark is classified under Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

INTRINSIQ SPECIALTY SOLUTIONS, INC. (21 trademarks)

Carrollton, TX 75010

Entity Type: 03

Trademark Details

Filing Date

November 6, 2015

Registration Date

January 23, 2018

First Use Anywhere

May 31, 2017

First Use in Commerce

May 31, 2017

Published for Opposition

September 27, 2016

Goods & Services

Health care services, namely, providing a database in the field of specialty healthcare information and featuring inputting and collection of clinical patient data and information all for analysis, treatment, and diagnostic purposes; health care services, namely, providing a database in the field of specialty healthcare information and featuring inputting and collection of medical records and information all for analysis, treatment, and diagnostic purposes; health care and medical services, namely, analyzing clinical patient data to determine and assess a patient's line of therapy

Filing History

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Aug 7, 2024 NA85
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Aug 7, 2024 C15A
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Aug 7, 2024 APRE
TEAS SECTION 8 & 15 RECEIVED
Jan 22, 2024 E815
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Jan 23, 2023 REM1
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Dec 17, 2021 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Dec 17, 2021 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Dec 17, 2021 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Dec 17, 2021 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Dec 17, 2021 COAR
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Dec 20, 2019 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Dec 20, 2019 COAR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Dec 20, 2019 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Dec 20, 2019 REAP
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Feb 20, 2019 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Feb 20, 2019 REAP
REGISTERED-PRINCIPAL REGISTER
Jan 23, 2018 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Dec 16, 2017 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Dec 15, 2017 CNPR
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Nov 29, 2017 EXRA
STATEMENT OF USE PROCESSING COMPLETE
Nov 28, 2017 SUPC
SOU EXTENSION 2 GRANTED
Nov 28, 2017 EX2G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Nov 27, 2017 AITU
USE AMENDMENT FILED
Nov 22, 2017 IUAF
SOU EXTENSION 2 FILED
Nov 22, 2017 EXT2
SOU TEAS EXTENSION RECEIVED
Nov 22, 2017 EEXT
TEAS STATEMENT OF USE RECEIVED
Nov 22, 2017 EISU
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 23, 2017 EXRA
SOU EXTENSION 1 GRANTED
May 20, 2017 EX1G
SOU EXTENSION 1 FILED
May 20, 2017 EXT1
SOU TEAS EXTENSION RECEIVED
May 20, 2017 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Nov 22, 2016 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 27, 2016 NPUB
PUBLISHED FOR OPPOSITION
Sep 27, 2016 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 7, 2016 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 19, 2016 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 13, 2016 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 12, 2016 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 12, 2016 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Feb 12, 2016 GNRN
NON-FINAL ACTION E-MAILED
Feb 12, 2016 GNRT
NON-FINAL ACTION WRITTEN
Feb 12, 2016 CNRT
ASSIGNED TO EXAMINER
Feb 5, 2016 DOCK
NOTICE OF PSEUDO MARK E-MAILED
Nov 13, 2015 MPMK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 12, 2015 NWOS
NEW APPLICATION ENTERED
Nov 10, 2015 NWAP

Related Trademarks

More from this Owner

ACTIVENGAGE

ACTIVENGAGE

ACTIVENGAGE

ACTIVENGAGE

CLINIQ PERSPECTIVES

CLINIQ PERSPECTIVES

CLINIQ PERSPECTIVES

CLINIQ PERSPECTIVES

CLINIQ PERSPECTIVES

CLINIQ PERSPECTIVES

TREATMENTFLOW

TREATMENTFLOW